Sensei Biotherapeutics (NASDAQ: SNSE)
FY 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-12-20 | ||||||
REV |
FY 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-11-09 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Sensei Biotherapeutics (NASDAQ: SNSE) through any online brokerage.
Other companies in Sensei Biotherapeutics’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Virios Therapeutics (NASDAQ:VIRI), Lumos Pharma (NASDAQ:LUMO), Evaxion Biotech (NASDAQ:EVAX) and Aligos Therapeutics (NASDAQ:ALGS).
The latest price target for Sensei Biotherapeutics (NASDAQ: SNSE) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 4.00 expecting SNSE to rise to within 12 months (a possible 81.00% upside). 50 analyst firms have reported ratings in the last year.
The stock price for Sensei Biotherapeutics (NASDAQ: SNSE) is $2.21 last updated August 12, 2022, 8:00 PM UTC.
The next Sensei Biotherapeutics (SNSE) dividend date is projected to be Thursday, September 1, 2022.
Sensei Biotherapeutics’s FY earnings are confirmed for Wednesday, December 20, 2023.
There is no upcoming split for Sensei Biotherapeutics.
Sensei Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.